Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First-line Treatment of Metastatic Pancreatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07621718
What this trial is testing

Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

Who this might be right for
Pancreatic CancerPancreatic Cancer MetastaticPDAC+5 more
Revolution Medicines, Inc. 670
Testing effectiveness (Phase 2)Looking for participantsNCT06962267
What this trial is testing

A Clinical Study on the First-line Treatment of Metastatic Pancreatic Cancer With TQB2916 Injection Combined With Gemcitabine Hydrochloride for Injection and Paclitaxel for Injection (Albumin-bound Type)

Who this might be right for
Pancreatic Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 50
Testing effectiveness (Phase 2)Looking for participantsNCT06572813
What this trial is testing

Bortezomib Combined with PD-1 MAb and MFOLFIRINOX for Metastatic Pancreatic Cancer

Who this might be right for
Pancreas Cancer
First Affiliated Hospital of Zhejiang University 63
Large-scale testing (Phase 3)Not Yet RecruitingNCT07656376
What this trial is testing

Clinical Trial of DN022150 Combined With AG Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12D Mutation

Who this might be right for
Pancreatic CancerPancreatic Carcinoma
Jiangxi Kvvit Pharmaceutical Co., Ltd. 465
Large-scale testing (Phase 3)UnknownNCT01586611
What this trial is testing

See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas Cancer

Who this might be right for
Metastatic Pancreas Cancer
AHS Cancer Control Alberta 175
Testing effectiveness (Phase 2)Looking for participantsNCT07444541
What this trial is testing

ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Anova Innovation Limited 84
Large-scale testing (Phase 3)Looking for participantsNCT07238283
What this trial is testing

Irinotecan Hydrochloride Liposome Injection (II)in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Metastatic Pancreatic Cancer

Who this might be right for
First-line Treatment of Metastatic Pancreatic Cancer
Jiangsu HengRui Medicine Co., Ltd. 662
Not applicableStudy completedNCT03620461
What this trial is testing

Gemcitabine and Nabpaclitaxel in Metastatic Pancreatic Carcinoma.

Who this might be right for
Metastatic Pancreatic Cancer
Galician Research Group on Digestive Tumors 210
Early research (Phase 1)Study completedNCT01189929
What this trial is testing

Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
OncoMed Pharmaceuticals, Inc. 57
Not applicableUnknownNCT04518800
What this trial is testing

PEG-rhG-CSF in Secondary Prevention of Nab-Paclitaxel Combined With S-1 in Advanced Pancreatic Cancer

Who this might be right for
PEG-rhG-CSFPancreatic Cancer
Chinese PLA General Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT01484860
What this trial is testing

Study of AUY922 in Metastatic Pancreatic Cancer Who Are Resistant to First Line Chemotherapy

Who this might be right for
Adenocarcinoma of the PancreasMetastatic Disease
University Health Network, Toronto 15
Large-scale testing (Phase 3)Study completedNCT00112658
What this trial is testing

Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
UNICANCER 342
Testing effectiveness (Phase 2)UnknownNCT00024362
What this trial is testing

BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery

Who this might be right for
Pancreatic Cancer
Theradex
Testing effectiveness (Phase 2)UnknownNCT02409849
What this trial is testing

Octreotide LAR as Maintenance Treatment for Patients With NEC

Who this might be right for
Gastro-entero-pancreatic CarcinomaEsophageal Neuroendocrine Carcinoma
Peking University 92
Testing effectiveness (Phase 2)Looking for participantsNCT05065801
What this trial is testing

Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients

Who this might be right for
Metastatic Pancreatic Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 162
Testing effectiveness (Phase 2)Study completedNCT03807999
What this trial is testing

Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine For The First Line Treatment of Pancreas Cancer

Who this might be right for
Pancreatic Neoplasm
Hacettepe University 125
Testing effectiveness (Phase 2)UnknownNCT05566743
What this trial is testing

A Study Evaluating Maintenance Therapy After First Line Chemotherapy in Metastatic Cancer Pancreas

Who this might be right for
Cancer of Pancreas
Menoufia University 40
Testing effectiveness (Phase 2)Ended earlyNCT01461915
What this trial is testing

Phase 2 Study to Assess the Efficacy & Safety of Gemcitabine + Nab Paclitaxel With or Without Dociparstat in Metastatic Pancreatic Cancer Patients

Who this might be right for
Metastatic Pancreatic Cancer
Jazz Pharmaceuticals 60
Early research (Phase 1)Active Not RecruitingNCT06532344
What this trial is testing

An Open-label, Uncontrolled Study of ONO-7913 and ONO-4538 in Combination With Modified FOLFIRINOX Therapy, the Standard of Care, as First-line Treatment in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Ono Pharmaceutical Co., Ltd. 32
Testing effectiveness (Phase 2)Ended earlyNCT01648465
What this trial is testing

Study of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine Tumors

Who this might be right for
Gastrointestinal TumorsPancreatic TumorsGastrointestinal Neuroendocrine Tumors+1 more
Hellenic Cooperative Oncology Group 25
Next Page